Atossa Therapeutics
ATOS
#9542
Rank
NZ$0.12 B
Marketcap
NZ$0.94
Share price
-5.83%
Change (1 day)
-37.80%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -NZ$51.93 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$42.35 Million, an increase over its 2023 earnings that were of -NZ$49.97 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$51.93 Million22.61%
2024 -NZ$42.35 Million-15.25%
2023 -NZ$49.97 Million11.62%
2022 -NZ$44.77 Million30.84%
2021 -NZ$34.22 Million15.58%
2020 -NZ$29.61 Million3.41%
2019 -NZ$28.63 Million51.16%
2018 -NZ$18.94 Million40.41%
2017 -NZ$13.49 Million27.54%
2016 -NZ$10.58 Million-47.49%
2015 -NZ$20.14 Million-17.25%
2014 -NZ$24.34 Million35.91%
2013 -NZ$17.91 Million112.3%
2012 -NZ$8.44 Million46.53%
2011 -NZ$5.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$53.79 B-107,442.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$2.13 B-4,364.41%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$2.21 B-4,517.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
NZ$69.2 M-238.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-NZ$0.19 Billion 261.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-NZ$13.02 Million-74.02%๐Ÿ‡บ๐Ÿ‡ธ USA